Supply Chain Intelligence

Palisade Bio, Inc. Supply Chain

PALI supply chain intelligence for Palisade Bio, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

PALI ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

7Suppliers
5Customers
2Debt Items
20Related Chains

Palisade Bio, Inc. Suppliers

TickerNameConfidenceEvidence
GIIANT GIIANT 92% The Company has an obligation to make contingent consideration payments to Giiant, in either cash or shares of the Company’s common stock solely at the Company’s election, upon the achievement of dev…
ITERATIVE-SCOPES-INC-D-B-A-ITERATIVE-HEALTH ITERATIVE-SCOPES-INC-D-B-A-ITERATIVE-HEALTH 90% pursuant to which IH has agreed to, among other things, assist the Company with the Study Enrollment
REGENTS-OF-THE-UNIVERSITY-OF-CALIFORNIA REGENTS-OF-THE-UNIVERSITY-OF-CALIFORNIA 80% the Company entered into three license agreements, as amended, with the Regents of the University of California
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from PALI graph: oduction: High-quality synthesis of active ingredients under stringent regulatory standards. • Formulation Development…
JNJ Johnson & Johnson 72% oduction: High-quality synthesis of active ingredients under stringent regulatory standards. • Formulation Development: Design and development of stable and effective drug formulations suitable for c…
ORANY ORANY 72% oduction: High-quality synthesis of active ingredients under stringent regulatory standards. • Formulation Development: Design and development of stable and effective drug formulations suitable for c…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from PALI graph: oduction: High-quality synthesis of active ingredients under stringent regulatory standards. • Formulation Developme…

Palisade Bio, Inc. Customers

TickerNameConfidenceEvidence
NEWSOARA NEWSOARA 90% During the three months ended March 31, 2026 and 2025, the Company recognized no license revenue from Newsoara under the Newsoara Co-Development Agreement.
JNJ Johnson & Johnson 72% oduction: High-quality synthesis of active ingredients under stringent regulatory standards. • Formulation Development: Design and development of stable and effective drug formulations suitable for c…
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from PALI graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from PALI graph: oduction: High-quality synthesis of a…
ORANY ORANY 72% oduction: High-quality synthesis of active ingredients under stringent regulatory standards. • Formulation Development: Design and development of stable and effective drug formulations suitable for c…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from PALI graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from PALI graph: oduction: High-quality synthesis …

Palisade Bio, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
PALI-DEBT-11652 Xbrl Convertible 90% xbrl convertible detail from xbrl 2014-12-31.
PALI-DEBT-11651 Warrants outstanding: 644138 90% xbrl warrant detail from xbrl 2026-03-31.

Palisade Bio, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Palisade Bio, Inc..

Palisade Bio, Inc. Ownership

HolderNameConfidenceEvidence
PALI-OWNER-JANUS-HENDERSON-GROUP-PLC JANUS HENDERSON GROUP PLC 90% 13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 98 tracked holders.

Palisade Bio, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
JNJ Johnson & Johnson 100.00 1 ['customer', 'supplier']
SNYNF Sanofi 100.00 2
ORANY ORANGE 100.00 1 ['customer', 'supplier']
AVTX Avalo Therapeutics, Inc. 100.00 2
BLTE Belite Bio, Inc 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
AUMN Golden Minerals Company 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
AMZE Amaze Holdings, Inc. 50.00 2
ANIK Anika Therapeutics, Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
AORT Artivion, Inc. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CYTOF Altamira Therapeutics Ltd. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
AVBP ArriVent BioPharma, Inc. 50.00 2
View PALI supply chain intel →

Explore the full interactive supply chain map for Palisade Bio, Inc..

Open PALI supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map